OpinionPublished 22 Jun 2022
Selective serotonin reuptake inhibitors usage in children and adolescents
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Depressive disorders are common in young individuals, and they are commonly neglected or undertreated. The use of antidepressants to treat depression in children and adolescents is debatable. Selective Serotonin Reuptake Inhibitors (SSRIs) were widely used in paediatric depression until cautions were published concerning their usage due to concerns that children and adolescents who had participated in trials testing the effectiveness of SSRIs were at an increased risk of self-harm. As a result, government regulatory organizations conducted detailed assessments of the studies and decided that only fluoxetine should be approved for use in children and adolescents with depressive disorders.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Psychiatry and Neuroscience
- SubjectMental Health and Psychology
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Gaurav Singh Dangi”
